Literature DB >> 3282357

Increased expression of major histocompatibility antigens in the liver as a result of cholestasis.

G K Innes1, Y Nagafuchi, B J Fuller, K E Hobbs.   

Abstract

Increased expression of major histocompatibility complex (MHC) antigens may occur following liver transplantation. The mechanism by which this occurs is unclear. Postoperative complications may result in cholestasis. We have investigated the possibility that cholestasis may cause increased expression of MHC antigens in the liver. Cholestasis was induced in rat livers by bile duct ligation and transection. Total serum bilirubin rose markedly postoperatively and remained elevated over a period of 21 days. Samples of bile taken from rats were shown to remain sterile during the study period and there was no evidence of viral infection. Liver tissue taken 1, 3, 7, and 21 days postobstruction showed a marked increase in the expression of rat class I MHC antigens but not class II antigens. We suggest that cholestasis itself can induce increased MHC class I antigens in the liver. Therefore, if cholestasis occurs postoperatively in the human liver transplant recipient this might lead to increased expression of human class I MHC antigens and add to the overall cellular immune activity in a rejection reaction, although cholestasis probably cannot initiate rejection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282357     DOI: 10.1097/00007890-198804000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Distribution of the MHC antigens after liver transplantation: relationship with biochemical and histological parameters.

Authors:  P Rouger; J Gugenheim; P Gane; M Capron-Landereau; F Michel; M Reynes; J Bismuth
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

2.  Effects of chenodeoxycholic and ursodeoxycholic acids on interferon-gamma production by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.

Authors:  R Saeki; H Ogino; S Kaneko; M Unoura; K Kobayashi
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

3.  Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression.

Authors:  F Hirano; H Tanaka; Y Makino; K Okamoto; I Makino
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

Review 4.  Chronic liver disease: current concepts of disease mechanisms.

Authors:  S A Center
Journal:  J Small Anim Pract       Date:  1999-03       Impact factor: 1.522

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.